867 results on '"Hossfeld, D. K."'
Search Results
2. Systemic Therapy of Disseminated Soft Tissue Sarcomas
3. Bleeding Complication following Tooth Extraction in a Hemophilia A Patient with Inhibitor — A Case Report
4. Entwicklung der Therapie des Ovarialkarzinoms
5. The Prognostic Impact of Trisomy 8 in Acute Myeloid Leukemia: Do Accompanying Aberrations Influence Prognosis?
6. Bone Marrow Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
7. Prinzipien der Tumorbiologie
8. Leukemia
9. Malignant Lymphoma and Multiple Myeloma
10. Cancer of the Testis
11. Cancer of the Ovary
12. Cancers of the Uterine Cervix and Endometrium and Gestational Trophoblastic Disease
13. Lung Cancer
14. Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
15. Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
16. Aclacinomycin A/Etoposide Combination Therapy for Advanced Relapsed Acute Myeloid Leukemia: A Phase II Study of the Arbeitsgemeinschaft Internistische Onkologie
17. Indikationen und Ergebnisse der second-look-Operation bei chemotherapierten Patienten mit metastasiertem Magenkarzinom
18. Gibt es eine sinnvolle adjuvante (intraoperative) Chemotherapie beim kolorektalen Karzinom?
19. Cancer of the Female Genital Organs
20. Leukemia
21. Multiple Myeloma
22. Malignant Lymphoma
23. Bone and Soft Tissue Cancer
24. Cancer of the Testis
25. Breast Cancer
26. Effects of Verapamil on Anthracycline-Induced Cardiomyopathy: Preliminary Results of a Prospective Multicenter Trial
27. Aclacinomycin A/Etoposide Combination Therapy for Advanced Relapsed Acute Myeloid Leukemia: Results of a Pilot Study of the Arbeitsgemeinschaft Internistische Onkologie
28. High-Dose Chemotherapy with Busulfan, Cyclophosphamide, and VP-16 as Conditioning for Allogeneic and Autologous Bone Marrow Transplantation for Patients with Acute Myeloid Leukemia
29. Interferon-α-2b + fotemustine in disseminated malignant melanoma
30. Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy)
31. Prognostic Significance of the Karyotype in Patients with Primary Myelodysplastic Syndrome
32. Prognostic Significance of Chromosome Analysis in De Novo Acute Myeloid Leukemia
33. Phase I/II trial of multicycle high-dose chemotherapy with peripheral blood stem cell support for treatment of advanced ovarian cancer
34. Therapie des hormonresistenten Prostatakarzinoms mit Docetaxel: Indikation, Voraussetzungen und Durchführung – Ergebnisse eines interdisziplinären Expertenworkshops, Berlin 22.–23.07.2005
35. Bioptische Sicherung muskuloskelettaler Tumoren
36. Antiangiogenic treatment with endostatin inhibits progression of AML in vivo
37. Gender aspects in chronic myeloid leukemia: long-term results from randomized studies
38. Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C
39. Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas
40. Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon α
41. A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma
42. Randomized comparison of interferon α and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon α and hydroxyurea
43. Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation
44. IgM myeloma: a report of four cases
45. ASHAP – an effective salvage therapy for recurrent and refractory malignant lymphomas
46. Origin of stroma cells in long-term bone marrow cultures from patients with acute myeloid leukemia
47. 12 month molecular response < 1% BCR-ABL (IS) is associated with improved overall and progression-free survival in CML patients: V635
48. Superior CMR-rates with tolerability-adapted imatinib 800 mg vs. 400 mg vs. 400 mg + IFN in CML: The randomized German CML-Study IV: V633
49. Therapy with imatinib in elderly CML patients (≥65 years): Results of the German CML-Study IV: V632
50. The prognostic significance of molecular and cytogenetic response landmarks after 3 months of imatinib in the upfront treatment of chronic myeloid leukemia: V637
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.